nach oben

Indian Journal of Hematology and Blood Transfusion

Erschienen in:

06.11.2015 | Original Article

Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran

verfasst von: Mohammad Hossein Ahmadi, Sedigheh Hantuoshzadeh, Mohammad Ali Okhovat, Nahid Nasiri, Azita Azarkeivan, Naser Amirizadeh

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

The prenatal determination of the fetal Rh genotype could lead to a substantial reduction in the use of anti-D immunoglobulin and prevention of unnecessary exposure of pregnant women carrying RhD negative fetus. The aim of this study was fetal RHD genotyping through the analysis of cffDNA in plasma samples of RhD negative pregnant women by real-time PCR technique. In this experiment, 30 plasma samples were collected from RhD negative pregnant women. DNA were extracted and real-time PCR reactions were done by specific primers for RHD, SRY and beta-globin (GLO) genes. The Rh phenotypes of mothers and their babies were determined by agglutination method and specific anti-serums. From the 30 maternal plasma samples considered for SRY genotyping, 16 samples revealed the presence of the SRY gene. Regarding the fetal RHD genotyping, 26 samples were positive for RhD and 4 samples were negative. In all cases, the predicted RhD and SRY genotypes were in concordance with the serologically determined phenotypes. The sensitivity, specificity and precision of the fetal RHD and SRY genotyping test were calculated 100 % (p value <0.0005; K = 100 %). The present study confirms the precision of fetal RHD and SRY genotyping in maternal plasma by real-time PCR technique. This method helps RhD negative pregnant women about the appropriate use of anti-D immunoglobulin and also on the management and prevention of HDFN. However, superior and confirmatory studies are recommended before fetal RHD genotyping by real-time PCR is introduced as a non-invasive prenatal screening test.

Oliveira J, Osório N, Rocha J, Cruz B, Figueiredo J, Caseiro A, Valado A, Gabriel A, Mendes F (2012) Fetal RHD and RHCE genotyping in plasma of Rh negative pregnant women. Int J Biomed Lab Sci (IJBLS) 1.1(2):50–58

Van Kim CL, Colin Y, Cartron JP (2006) Rh proteins: key structural and functional components of the red cell membrane. Blood Rev 20(2):93–110. doi:10.1016/j.blre.2005.04.002 CrossRefPubMed

Flegel WA (2006) Molecular genetics of RH and its clinical application. Transfusion clinique et biologique: journal de la Societe francaise de transfusion sanguine 13(1–2):4–12. doi:10.1016/j.tracli.2006.02.011 CrossRef

Daniels G (2013) Variants of RhD–current testing and clinical consequences. Br J Haematol 161(4):461–470. doi:10.1111/bjh.12275 CrossRefPubMed

Avent ND, Reid ME (2000) The Rh blood group system: a review. Blood 95(2):375–387PubMed

Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Kulovany E, Vlk R (2005) Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Fetal Diagn Ther 20(4):275–280. doi:10.1159/000085085 CrossRefPubMed

Wikman AT, Tiblad E, Karlsson A, Olsson ML, Westgren M, Reilly M (2012) Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol 120(2 Pt 1):227–234. doi:10.1097/AOG.0b013e31825d33d9 CrossRefPubMed

Bowman JM, Chown B, Lewis M, Pollock JM (1978) Rh isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J 118(6):623–627PubMedPubMedCentral

Legler TJ, Muller SP, Haverkamp A, Grill S, Hahn S (2009) Prenatal RhD testing: a review of studies published from 2006 to 2008. Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 36(3):189–198. doi:10.1159/000216580 CrossRef

10.

McIntosh RV, Welch AG (1995) Hepatitis C infection from anti-D immunoglobulin. Lancet 346(8971):372CrossRefPubMed

11.

Liumbruno GM, D’Alessandro A, Rea F, Piccinini V, Catalano L, Calizzani G, Pupella S, Grazzini G (2010) The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation. Blood Transfus 8(1):8–16. doi:10.2450/2009.0108-09 PubMedPubMedCentral

12.

Kumpel BM (2008) Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn. Clin Exp Immunol 154(1):1–5. doi:10.1111/j.1365-2249.2008.03735.x CrossRefPubMedPubMedCentral

13.

van der Schoot CE, Hahn S, Chitty LS (2008) Non-invasive prenatal diagnosis and determination of fetal Rh status. Semin fetal Neonatal Med 13(2):63–68. doi:10.1016/j.siny.2007.12.012 CrossRefPubMed

14.

Amaral DR, Credidio DC, Pellegrino J Jr, Castilho L (2011) Fetal RHD genotyping by analysis of maternal plasma in a mixed population. J Clin Lab Anal 25(2):100–104. doi:10.1002/jcla.20440 CrossRefPubMed

15.

Clausen FB (2014) Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care. Prenat Diagn 34(5):409–415. doi:10.1002/pd.4326 CrossRefPubMed

16.

Hill M, Finning K, Martin P, Hogg J, Meaney C, Norbury G, Daniels G, Chitty LS (2011) Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 80(1):68–75. doi:10.1111/j.1399-0004.2010.01533.x CrossRefPubMed

17.

Urbaniak SJ, Greiss MA (2000) RhD haemolytic disease of the fetus and the newborn. Blood Rev 14(1):44–61. doi:10.1054/blre.1999.0123 CrossRefPubMed

18.

Daniels G, Finning K, Martin P, Summers J (2006) Fetal blood group genotyping: present and future. Ann N Y Acad Sci 1075:88–95. doi:10.1196/annals.1368.011 CrossRefPubMed

19.

Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS (1997) Presence of fetal DNA in maternal plasma and serum. Lancet (London, England) 350(9076):485–487. doi:10.1016/s0140-6736(97)02174-0 CrossRef

20.

Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, Soothill PW (2007) Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 27(5):415–418. doi:10.1002/pd.1700 CrossRefPubMed

21.

Masuzaki H, Miura K, Yoshiura K, Yoshimura S, Niikawa N, Ishimaru T (2004) Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism. J Med Genet 41(4):289–292. doi:10.1136/jmg.2003.015784 CrossRefPubMedPubMedCentral

22.

Flori E, Doray B, Gautier E, Kohler M, Ernault P, Flori J, Costa JM (2004) Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Human Reprod 19(3):723–724. doi:10.1093/humrep/deh117 CrossRef

23.

Huppertz B, Kadyrov M, Kingdom JC (2006) Apoptosis and its role in the trophoblast. Am J Obstet Gynecol 195(1):29–39. doi:10.1016/j.ajog.2005.07.039 CrossRefPubMed

24.

Birch L, English CA, O’Donoghue K, Barigye O, Fisk NM, Keer JT (2005) Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 51(2):312–320. doi:10.1373/clinchem.2004.042713 CrossRefPubMed

25.

Galbiati S, Smid M, Gambini D, Ferrari A, Restagno G, Viora E, Campogrande M, Bastonero S, Pagliano M, Calza S, Ferrari M, Cremonesi L (2005) Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 117(2–3):243–248. doi:10.1007/s00439-005-1330-z CrossRefPubMed

26.

Yu SC, Lee SW, Jiang P, Leung TY, Chan KC, Chiu RW, Lo YM (2013) High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing. Clin Chem 59(8):1228–1237. doi:10.1373/clinchem.2013.203679 CrossRefPubMed

27.

Machado IN, Castilho L, Pellegrino J Jr, Barini R (2006) Fetal rhd genotyping from maternal plasma in a population with a highly diverse ethnic background. Revista da Associação Médica Brasileira 52:232–235CrossRefPubMed

28.

Finning K, Martin P, Daniels G (2004) A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 1022:119–123. doi:10.1196/annals.1318.019 CrossRefPubMed

29.

Dziegiel MH, On behalf of the Danish Network for Antenatal RHDS (2012) Noninvasive prenatal screening for RHD: the 1st national antenatal directed anti-D prophylaxis program—the Danish model or a guide to robust prediction of need of anti-D. ISBT Sci Ser 7(1):160–163. doi:10.1111/j.1751-2824.2012.01562.x CrossRef

30.

Clausen FB, Damkjær MB, Dziegiel MH (2014) Noninvasive fetal RhD genotyping. Transfus Apheres Sci 50(2):154–162. doi:10.1016/j.transci.2014.02.008 CrossRef

31.

Daniels G, Finning K, Martin P, Massey E (2009) Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 29(2):101–107. doi:10.1002/pd.2172 CrossRefPubMed

32.

van der Schoot CE, Tax GH, Rijnders RJ, de Haas M, Christiaens GC (2003) Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 17(1):31–44. doi:10.1053/tmrv.2003.50001 CrossRefPubMed

33.

Aykut A, Onay H, Sagol S, Gunduz C, Ozkinay F, Cogulu O (2013) Determination of fetal rhesus d status by maternal plasma DNA analysis. Balkan J Med Genet BJMG 16(2):33–38. doi:10.2478/bjmg-2013-0029 PubMed

34.

Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Vlk R (2005) Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies. J Histochem Cytochem Off J Histochem Soc 53(3):301–305. doi:10.1369/jhc.4A6372.2005 CrossRef

35.

Schmidt LC, Cabral AC, Faria MA, Monken F, Tarazona-Santos E, Martins ML (2014) Noninvasive fetal RHD genotyping from maternal plasma in an admixed Brazilian population. Genet Mol Res GMR 13(1):799–805. doi:10.4238/2014.February.7.1 CrossRefPubMed

36.

Randen I, Hauge R, Kjeldsen-Kragh J, Fagerhol MK (2003) Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang 85(4):300–306CrossRefPubMed

37.

Wang XD, Wang BL, Ye SL, Liao YQ, Wang LF, He ZM (2009) Non-invasive foetal RHD genotyping via real-time PCR of foetal DNA from Chinese RhD-negative maternal plasma. Eur J Clin Invest 39(7):607–617. doi:10.1111/j.1365-2362.2009.02148.x CrossRefPubMed

38.

Chiu RW, Lo YM (2011) Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med 16(2):88–93. doi:10.1016/j.siny.2010.10.003 CrossRefPubMed

39.

Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM (2006) Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52(12):2211–2218. doi:10.1373/clinchem.2006.074997 CrossRefPubMed

Titel: Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran
verfasst von: Mohammad Hossein Ahmadi
Sedigheh Hantuoshzadeh
Mohammad Ali Okhovat
Nahid Nasiri
Azita Azarkeivan
Naser Amirizadeh
Publikationsdatum: 06.11.2015
Verlag: Springer India
Erschienen in: Indian Journal of Hematology and Blood Transfusion / Ausgabe 4/2016
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-015-0616-0

Springer Medizin

Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

The Interaction Between Niche and Hematopoietic Stem Cells

Chemotherapy and Radiation Induced Pulmonary Dysfunction in Hodgkin Lymphoma Patients

Genotyping of Intron Inversions and Point Mutations in Exon 14 of the FVIII Gene in Iranian Azeri Turkish Families with Hemophilia A

Differential Expression of T-bet and GATA3 in Egyptian Children with Idiopathic Thrombocytopenic Purpura

The Mysterious Story of Brown Blood and High Saturation Gap

Peri-anal Paraneoplastic Pemphigus Heralding the Relapse of Follicular Lymphoma and Its Successful Management by Rituximab: A Short Correspondence

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie